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Edited by Christian GriesingerAbstract Cellular synthesis of naturally occurring, bioactive
peptides requires the proprotein convertase PC2/EGL-3 for
cleavage from the larger peptide precursors. A neuroendocrine
chaperone 7B2 is needed for the proteolytical activation of
proPC2, as extensively studied in mouse models. To determine
the role of its orthologue in Caenorhabditis elegans, we analyzed
wild-type and 7B2-null strains by HPLC and matrix-assisted
laser desorption ionization time-of-ﬂight mass spectrometry,
which allowed the identiﬁcation of a novel neuropeptide gene,
ﬂp-33. The presence and/or absence of some neuropeptides in
7B2-null animals strongly diﬀers form the peptide proﬁle in
wild-type, suggesting a speciﬁc and determined action of 7B2
in C. elegans.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Bioactive (neuro)peptides can be found in all metazoan spe-
cies where they orchestrate a wide array of behaviors and phys-
iological processes. Neuropeptides are derived from larger
preproproteins which require extensive post-translational pro-
cessing to yield the bioactive, mature peptides. After removal
of the aminoterminal signal peptide, the remaining part of
the precursor is processed by proprotein convertases (PCs) at
deﬁned cleavage motifs displaying mono- or dibasic residues.
Caenorhabditis elegans contains four kex2/subtilisin-like pro-
protein convertases (KPC) [1]. KPC-2 appears to be encoded
by egl-3 [2] from which diﬀerent alleles were originally identi-
ﬁed in a screen for egg-laying deﬁciency [3]. Since KPC-2/
EGL-3 is exclusively expressed in the nervous system [2] and
kpc-2/egl-3 mutants were found to be severely depleted in both
FMRFamide-like peptides (FLP) and neuropeptide-like pep-
tides (NLPs), KPC-2/EGL-3 can be considered as the major
PC in C. elegans [4]. Strains mutant in kpc-3/aex-5 only dis-Abbreviations: Da, Dalton; ﬂp, FMRF amide-like peptide; m/z, mass-
to-charge ratio; MALDI-TOF MS, matrix-assisted laser desorption
ionization time-of-ﬂight mass spectrometry; MS/MS, tandem mass
spectrometry; nlp, neuropeptide-like protein; PC, proprotein conver-
tase; sbt-1, seven-B-two-1
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doi:10.1016/j.febslet.2007.08.003played moderate peptide processing defects, while peptide
proﬁles of kpc-1 and kpc-4/bli-4 mutants are nearly wild-type
[4].
Mammalian PC2 requires the interaction with the neuroen-
docrine protein 7B2, which facilitates its transport and activa-
tion [5]. 7B2 is biosynthesized as a precursor protein that is
cleaved into an aminoterminal fragment and a carboxytermi-
nal peptide (CT peptide). Moreover, 7B2 has a dual function
since the generated CT peptide regulates the enzymatic activity
of mature PC2 [6], while the aminoterminal domain functions
as a speciﬁc chaperone for the proteolytic maturation and acti-
vation of proPC2 [5]. In the fruit ﬂy, Drosophila proprotein
convertase 2 (dPC2) also requires d7B2 for its activation [7].
The C. elegans 7B2 gene (sbt-1) has already been cloned in
1998 [8] and appears to be expressed in the nervous system
[9]. In contrast to the well-studied mouse model, no biochem-
ical data about the eﬀects of 7B2 on neuropeptide processing in
C. elegans is currently available. Here, we describe a diﬀeren-
tial peptidomics analysis of wild-type C. elegans versus a 7B2
mutant and compare the generated peptide proﬁles.2. Materials and methods
2.1. Strains
Wild-type C. elegans (N2, variety Bristol) and the RB987 strain that
contains the ok901 allele of the sbt-1 (T03D8.3) gene were cultivated on
nematode growth media (NGM) plates containing Escherichia coli
OP50 bacterial lawns at 20 C.
2.2. Peptide extraction and sample preparation
Endogenous peptides were extracted from C. elegans as previously
described [10], using 12 fully grown Petri dishes (diameter 90 mm) as
starting material. The nematodes were placed in 20 ml of an ice cold
extraction solvent containing methanol/water/acetic acid (90/9/1, v/v/
v). After homogenization, sonication and centrifugation, the pellet
was discarded and the methanol was evaporated before re-extraction
with ethyl acetate. The organic solvent layer was decanted and the
aqueous solution was subsequently desalted by solid phase extraction
using a SepPak C18 cartridge (Waters, Milford, MA). Just prior to
HPLC analysis, samples were lyophilized and reconstituted in 500 lL
of water containing 2% CH3CN and 0.1% TFA and ﬁltered through
a 22 lm spin down ﬁlter.
2.3. High-performance liquid chromatography (HPLC)
Oﬀ-line HPLC analyses were performed using a liquid chromato-
graph (Beckmann, Fullerton, CA) equipped with a Symmetry C18
column (5 lm, 4.6 · 250 mm, Waters). After injection of the peptide
extract, a wash step for 10 min using 2% CH3CN in 0.1% aqueous
TFA was initiated, followed by a linear three-step gradient of 60 min-
utes at a ﬂow-rate of 1 ml/min. The gradient was programmed from 2%
CH3CN to 22% CH3CN in 0.1% aqueous TFA in 20 min, from 22%
CH3CN to 37% CH3CN in 0.1% aqueous TFA in 30 min and fromblished by Elsevier B.V. All rights reserved.
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fractions of 1 ml were automatically collected from the beginning of
the three-step gradient.
2.4. Matrix-assisted laser desorption ionization time-of-ﬂight mass
spectrometry (MALDI-TOF MS)
All generated HPLC fractions were screened by MALDI-TOF MS
using an Ultraﬂex II instrument (Bruker Daltonics, GmbH, Bremen,
Germany). One-fourth of each HPLC fraction was lyophilized and
resuspended in 1 lL water/CH3CN/TFA (50/49.9/0.1) and subse-
quently transferred to a stainless steel target plate and mixed with
1 lL of a saturated a-cyano-4-hydroxy cinnamic acid in acetone solu-
tion. The instrument was operated in positive ion, reﬂectron mode and
calibrated using a standard peptide mixture (Bruker Daltonics). Spec-
tra were recorded within a mass range from m/z 500 to m/z 4000. Ion
peaks were compared with the theoretical masses of predicted and pre-
viously identiﬁed neuropeptides from C. elegans. In order to ﬁnd novel
endogenous peptides (these that have not been predicted from the gen-
ome), ion peaks having satisfying intensity were fragmented to gain se-
quence information. The generated fragmentation data were submitted
to a MASCOT search that matches the MS/MS data against the pro-
tein database of C. elegans.3. Results
3.1. Compare wise sequence analysis of C. elegans 7B2
Although much structural and functional information is
available about the neuroendocrine protein 7B2 in mice, veryFig. 1. Alignment of 7B2 sequences and gene structure of the Caenorhabditis
and Brugia malayi were aligned with their mammalian homologues from
containing the PPNPCP motif and the internal cleavage site RRKR appear t
by the box. The inhibitory eﬀect of the CT peptide is terminated by cleavage a
elegans sbt-1 gene contains three exons as shown by the numbered black boxe
by the grey bar and most likely totally abolishes the expression of 7B2, sinclittle about its orthologue in nematodes is known so far. There-
fore, we compared the amino acid sequences of nematode 7B2
proteins with their mammalian counterparts in mice and hu-
man (Fig. 1A). A polyproline helix-like structure containing
the PPNPCP motif appears to be present in 7B2 from C. ele-
gans (CAB07408), C. briggsae (CAE61637), Brugia malayi
(AAZ83722), Mus musculus (NP_033188) and Homo sapiens
(NP_003011). This conserved motif contributes to 7B2 activity
and is critical for binding of 7B2 to proPC2 [11]. Another
highly conserved motif is the internal cleavage site (RRKR)
to generate the carboxyterminal peptide or CT peptide. The
inhibitory eﬀect of the CT peptide is terminated by cleavage
of this peptide at the conserved KK site [12]. All key motifs
of 7B2 required for binding to proPC2 and proteolytic activa-
tion of this zymogen, as well as the inhibitory CT peptide and
its internal cleavage site appear to be conserved from mammals
to nematodes.3.2. Diﬀerential peptidomics of 7B2 mutant animals versus wild-
type C. elegans
A 1382 bp deletion in the ok901 allele of sbt-1 most likely to-
tally abolishes the expression of 7B2, since the promotor re-
gion as well as the ﬁrst exon is deleted, as indicated in
Fig. 1B. Peptide extracts from wild-type C. elegans and the
7B2-null strain underwent a RP-HPLC separation, using aelegans 7B2 gene sbt-1. (A) 7B2 sequences from C. elegans, C. briggsae
Mus musculus and Homo sapiens. A polyproline helix-like structure
o be conserved. The carboxyterminal peptide (CT peptide) is indicated
t the highly conserved KK motif, as indicated by the arrow. (B) The C.
s. The ok901 allele of sbt-1 has a 1382 bp deletion which is represented
e the promotor region as well as the ﬁrst exon is deleted.
Fig. 2. RP-HPLC chromatograms from wild-type N2 and sbt-1(ok901) Caenorhabditis elegans. Peptide extracts from wild-type N2 (A) and the
RB987 strain having the ok901 allele of the 7B2 gene sbt-1 (B), were separated by RP-HPLC on a Symmetry C18 column (5 lm, 4.6 · 250 mm). After
a washing step of 10 min, a three-step gradient was initiated. The resulting chromatograms, as monitored by UV absorption at 214 nm, show a clear
decrease of peaks in the 7B2-null mutant especially from 22% CH3CN to 37% CH3CN, where most endogenous neuropeptides elute.
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grams show a clear reduction of peaks in the 7B2 mutant, espe-
cially from 22% CH3CN to 37% CH3CN, where most of the
neuropeptides tend to elute. All generated HPLC fractions
were screened by MALDI-TOF MS to generate a peptide pro-
ﬁle for both strains (Table 1, Supplementary material). This
way, 91 endogenous peptides could be detected in the wild-
type strain, in contrast to ‘‘only’’ 41 peptides in the 7B2-null.
In fraction 35, for example, nine neuropeptides could be ob-
served in the wild-type extract, from which only four FLP-1
peptides were present in the 7B2-null (Fig. 3). Interestingly,
some ion peaks with high absolute intensities, like the FLP-
24 peptide VPSAGDMMVRFamide, are totally absent in
the mutant strain. Peptides that are present in the 7B2-null
strain, however, appear to be less abundant.
Previously, genetic, bioinformatics and biochemical analysis
revealed the presence of 29 ﬂp genes (ﬂp-1-to-ﬂp-28 and ﬂp-32),
which can be subdivided into four subfamilies according to the
carboxyterminal motifs of the encoded peptides (LRFamide,
IRFamide, MRFamide and VRFamide) [13,14]. Here, we re-
port the identiﬁcation of a novel FLP peptide, APLEGFED-
MSGFLRTIDGIQKPRFamide (2722.39 Da), that was foundby fragmentation of an ion peak observed in both wild-type
animals (m/z 2723.44) and in the 7B2 mutant strain (m/z
2723.38). To verify the sequence of the novel putative bioactive
peptide, a synthetic replicate was analyzed by MS/MS in ex-
actly the same way. Comparison of the respective fragmenta-
tion spectra conﬁrmed the obtained sequence of the novel
neuropeptide. Moreover, the originating preproprotein dis-
plays all features of a typical neuropeptide precursor, which
we suggest to annotate as FLP-33.4. Discussion
In the past, bioactive peptides were puriﬁed using laborious
and time-consuming chromatographic separations. All gener-
ated HPLC fractions had to be screened by an appropriate
bioassay in order to yield one biologically active peptide.
Mostly, multiple chromatographic separations had to be per-
formed in order to isolate an active compound into purity,
prior to characterization by Edman degradation. Using mass
spectrometry, however, (neuro)peptides can be isolated in a
high-throughput manner with greater resolution and speciﬁc-
Fig. 3. Comparison of MALDI-TOFMS read outs from wild-type N2 and sbt-1(ok901) animals. Each fraction of RP-HPLC separations of peptide
extracts from wild-type Caenorhabditis elegans and 7B2-null animals were analyzed by MALDI-TOFMS. As an example, zoom regions from m/z 900
to m/z 1550 of fraction 35 (other fractions not shown) from the wild-type extract (A) and the sbt-1(ok901) mutant (B) are shown. In total, 91
endogenous peptides were monitored in the wild-type extract, while 41 peptides appeared to be present in the 7B2-null.
S.J. Husson, L. Schoofs / FEBS Letters 581 (2007) 4288–4292 4291ity from various biological tissue extracts. A few years ago,
we introduced MS-based ‘‘peptidomics’’ approaches for the
characterisation of endogenous (bioactive) peptides, to clearly
distinguish it from ‘‘proteomics’’, where on-bench generated
tryptic peptides are used to identify the corresponding pro-
tein. Here, we used a ‘‘diﬀerential peptidomics’’ approach to
study the eﬀect of 7B2 on neuropeptide processing in C. ele-
gans. While 41 out of 91 observed peptides from wild-type
N2 were unequivocally present in the 7B2 mutant, a clear ab-
sence of some deﬁned ion peaks could be monitored in the
latter strain. This speciﬁc and determined absence or presence
of a subset of FLP and NLP peptides was clearly not ob-
served in strains mutant for kpc-2/egl-3. A similar mass spec-
trometric peptide proﬁling study of ﬁve diﬀerent kpc-2/egl-3
mutant strains only revealed the presence of a few peptides,while a moderate reduction of the peptide proﬁle could be ob-
served for kpc-3/aex-5 mutants [4]. These results suggest that
7B2 is not per se required for the proteolytical activation of
KPC-2/EGL-3 (in some cells). It might also be possible that
an additional convertase like KPC-3/AEX-5 is involved in
the activation of KPC-2/EGL-3 or in the processing of neuro-
peptides.
The next step in the neuropeptide processing pathway is the
removal of carboxyterminal basic amino acids from the inter-
mediate peptides by a carboxypeptidase. As 115 incompletely
processed peptides could be found in egl-21 mutants, EGL-
21 can be considered as the major carboxypeptidase, needed
for the proper processing of neuropeptides in C. elegans [15].
Mutant kpc-2/egl-3 strains retain late-stage embryos, have a
mild coiling phenotype, and display altered defecation, which
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boxypeptidase EGL-21 [3,16]. In contrast, kpc-3/aex-5, which
was ﬁrst identiﬁed in a genetic screen for speciﬁc defecation
phenotypes [17], does not show a coiling locomotion, nor does
the 7B2 mutant. Secretion of acetylcholine can be assayed by
measuring resistance to the acetylcholinesterase inhibitor aldi-
carb. Not only mutations in kpc-2/egl-3 and egl-21 lead to aldi-
carb resistance [16], but loss of sbt-1 expression also results in
resistance to the drugs [9].
Interestingly, deﬁciency of 7B2 does not mimic phenotypes
observed in PC2 knock-out mice models. 7B2-null mutants
die early in life from Cushing’s disease and suﬀer from many
other atypical symptoms [18], while PC2-null mice are viable
[19]. These observations, however, have to be interpreted very
carefully, as the two null mice strains have a diﬀerent genetic
background [20]. Substantial diﬀerences in the processing of
neuropeptide precursors can also be observed in PC2-null
and 7B2-null mice [18,19], as we now demonstrated for the
C. elegansmodels. In conclusion, we were able to identify a no-
vel neuropeptide gene ﬂp-33 that encodes a single peptide hav-
ing a unique PRFamide motif and we provided direct
biochemical evidence that 7B2 is involved in the processing
of both NLP and FLP neuropeptides in C. elegans in a speciﬁc
and determined way.
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